Adjuvants and excipients in the experimental vaccine and the comparator used in the Danish part of the Future II trial (501-015) according to information from the Danish Medicines Agency and the Danish National Committee on Health Research Ethics
| Agency/committee | Composition of the experimental vaccine | Composition of the comparator |
| Danish Medicines Agency Danish National Committee on Health Research Ethics | 225 mcg aluminium as potassium aluminium sulfate 9.56 mg sodium chloride 0.78 mg L-histidine 50 mcg polysorbate 80 35 mcg borax | 225 mcg aluminium as potassium aluminium sulfate 9.56 mg sodium chloride 0.78 mg L-histidine 50 mcg polysorbate 80 35 mcg borax |
| Protocol | 225 mcg aluminium as amorphous aluminium hydroxyphosphate sulfate (Merck aluminium adjuvant) | Merck standard aluminium diluent (225 µg alum) in normal saline, unique selling proposition (NaCl 0.9%) or Merck aluminium adjuvant placebo |
| Recruitment brochure | No information | Saline |
| Informed consent form | No information | Saline |